Observational studyThe Journal of nutrition2026
Factors Associated with Produce Prescription Program Enrollment and Benefit Use among Patients with Diabetes and at Risk for Food Insecurity.
Observational study in The Journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05896644 (An Evaluation of Eat Well, a Produce Benefit, for Patients With Diabetes and At-risk for Food Insecurity), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
An Evaluation of Eat Well, a Produce Benefit, for Patients With Diabetes and At-risk for Food Insecurity
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundFood insecurity (FI) exacerbates type 2 diabetes (T2D) by limiting access to nutritious foods and worsening glycemic control. Produce prescription (PRx) programs subsidize fruits and vegetables to improve food security and diet quality, yet factors associated with PRx engagement patterns remain understudied.
objectivesThis study aimed to evaluate factors associated with enrollment and benefit use in a PRx program among patients with T2D at risk for FI.
methodsThis observational cohort study analyzed participants from a pragmatic randomized trial in a large integrated health system. Eligible adults (≥18 y) had recent glycated hemoglobin measurements and FI risk based on Medicaid enrollment, high Area Deprivation Index (ADI ≥7), or documented unmet social needs. Of 9644 contacted, 2177 enrolled and were randomly divided 2:1 to receive the EatWell PRx program, receiving a reloadable debit card providing $80/mo for 12 mo to purchase fruits and vegetables. We examined predictors of: 1) study enrollment, 2) any spending (>$0), 3) high spending (>$53/mo median), and 4) highest spending (>$70/mo). Multivariate logistic regression included demographic, socioeconomic, and clinical covariates.
resultsOf the 9644 contacted, 2177 enrolled (22.6%), 1450 were assigned to the PRx arm, and 1148 (79.2% of enrollees) activated their cards. Enrollment was lower among older adults [per 10-y increase: odds ratio (OR): 0.75; 95% confidence interval (CI): 0.72, 0.77], males (OR: 0.57; 95% CI: 0.51, 0.63), Medicaid enrollees (OR: 0.61; 95% CI: 0.53, 0.69), high-ADI (OR: 0.62; 95% CI: 0.55, 0.70), and non-Hispanic White (OR: 0.76; 95% CI: 0.68, 0.85) and Hispanic/Latino (OR: 0.72; 95% CI: 0.57, 0.90) participants compared with Black participants. Among card activators, high spending was associated with older age (OR: 1.15; 95% CI: 1.04, 1.27), whereas highest spending was associated with being married (OR: 1.43; 95% CI: 1.03, 1.96) and Black compared with White race (OR: 1.56; 95% CI: 1.09, 2.22).
conclusionsDemographic and socioeconomic factors are significantly associated with PRx enrollment and utilization. Multimodal outreach strategies and targeted implementation approaches may be necessary to ensure equitable program reach and effectiveness. This trial is registered at clinicaltrials.gov as NCT05896644.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.